2020 |
Varadarajan et al. [68]
|
DME |
CNN (InceptionV3) |
Thailand (4732) / EyePACS-DME (554) |
Center-involved DME |
0.890 |
0.850 |
0.800 |
Yes (3) |
|
|
|
|
|
Intraretinal fluid |
0.810 |
|
|
|
|
|
|
|
|
Subretinal fluid |
0.880 |
|
|
|
2020 |
Singh and Gorantla [71]
|
DME |
CNNs (Hierarchical Ensemble of 5) |
Messidor (1200) / IDRiD (516) |
DME |
|
0.947/ 0.979 |
0.972/ 0.945 |
|
|
|
|
|
|
DME: (three-class grading) |
|
0.964 |
0.958 |
|
2019 |
Arsalan et al. [23]
|
DR, Vessel seg. |
CNN (Custom, Vess-Net) |
DRIVE (40) / CHASE-DB1 (128) / STARE (20) |
Vessel segmentation map |
0.980–0.988 |
0.802–0.853 |
0.979–0.984 |
|
2019 |
Sayres et al. [69]
|
DR |
CNN (InceptionV4) |
Patients from Krause2018 (1612) |
DR: None, mild, moderate, severe, prolif. |
|
0.925 |
0.946 |
Yes (10) |
2019 |
Cao et al. [22]
|
DR |
Naive Bayes on grey coocurrence matrix |
Private (1000) |
DR |
0.938 |
0.949 |
0.928 |
|
2019 |
Yang et al. [67]
|
DR |
CNN (IDx-DR) |
Private (500) |
DR: None, mild, moderate, severe, prolif. |
|
0.988 |
0.880 |
|
2019 |
Peng et al. [70]
|
AMD (Bilateral images) |
CNN (Inceptionv3: DeepSeeNet) |
AREDS (4549) |
AMD: AREDS early AMD progression risk scale (five classes) |
|
0.590 |
0.930 |
Yes (88) |
|
|
|
|
|
Drusen: Small / none, medium, large |
0.940 |
0.718 |
0.871 |
Yes |
|
|
|
|
|
Pigment. abnorm. |
0.930 |
0.732 |
0.957 |
Yes |
|
|
|
|
|
Late AMD |
0.970 |
0.627/ 0.538 |
0.987/ 0.898 |
No |
2019 |
Coyner et al. [50]
|
ROP |
CNN (InceptionV3) |
i-ROP (898) |
ROP: Image quality assesment (2 classes) |
0.9650 |
0.939 |
0.836 |
Same (6) |
2019 |
Tan et al. [72]
|
ROP |
CNN (ROP.AI) |
Australasian ART-ROP (500) |
ROP: Normal, plus-disease |
0.9770 |
0.939 |
0.807 |
|
|
|
|
|
|
ROP: Normal, pre-plus disease |
|
0.814 |
0.807 |
|
2018 |
Grassmann et al. [45]
|
AMD |
CNN (Ensemble of six) |
AREDS (3654) / KORA (5555) |
AMD: AREDS scale (13 classes) |
|
0.538/0.328 |
0.969/0.957 |
Yes |
2018 |
Rajalakshmi et al. [73]
|
DR (Phone images) |
CNN (EyeArt) |
Private (296) |
DR grade: Any, DME, prolif., referrable |
|
0.781–0.993 |
0.688–0.898 |
|
2018 |
Kanagasingam et al. [74]
|
DR |
CNN (IDx-DR) |
Private (193) |
DR: None, mild, moderate, severe, prolif. |
|
|
0.920 |
|
2018 |
Krause et al. [36]
|
DR |
CNN (InceptionV4) |
EyePACS (242252) |
DR: None, mild, moderate, severe, prolif. |
0.986 |
0.970 |
0.917 |
Same (6) |
2018 |
Brown et al. [52]
|
ROP |
CNN (Vessel seg.: U-Net) + CNN (Classif.: InceptionV1) |
i-ROP (898) |
ROP |
0.940 |
0.930 |
0.940 |
Yes (8) |
|
|
|
|
|
ROP: Plus disease |
0.980 |
1,000 |
0.940 |
|
2018 |
Wang et al. [51]
|
ROP |
CNN (custom, Inception-like) |
Chengdu Women Children's Central Hospital (1273) |
ROP |
|
0.849 |
0.969 |
Same (3) |
|
|
|
|
|
ROP: Minor, severe |
|
0,736 |
0,933 |
|
2017 |
Li et al. [16]
|
Glaucoma |
CNN (InceptionV3) |
Guangdong (3970) |
Glaucoma: Referable, nonreferable |
0.986 |
0.956 |
0.920 |
|
2017 |
Gargeya and Leng [34]
|
DR |
CNN (Custom) + Decission tree (Grad. Boosting) |
EyePACS (15000) / Messidor-2 (874) / E-Optha (100) |
DR: Referable, Non Referable |
0.940–0.970 |
0.900–0.940 |
0.870–0.980 |
|
2017 |
Ting et al. [39]
|
DR |
CNN (VGG-19) |
SIDRP 10-15 (27979) / Guangdong (3970) + 9 others |
DR: Referable, non referable |
0.889-0.983 |
0.905-1.000 |
0.733-0.916 |
|
|
|
Glaucoma |
|
SIDRP 10-15 (27979) + 5 others |
Glaucoma: Referable, non referable |
0.942 |
0.964 |
0.872 |
|
|
|
AMD |
|
Idem |
AMD: Referable, non referable |
0.931 |
0.932 |
0.887 |
|
2017 |
Burlina et al. [2]
|
AMD |
CNN (AlexNet) |
AREDS (4613) |
AMD |
0.940 |
0.846 |
0.920 |
Same |
2016 |
Abràmoff et al. [75]
|
DR |
CNN (IDx-DR vX2.1) |
Messidor-2 (874) |
DR: None or mild, present, vision-threatening |
0.980 |
0.968 |
0.870 |
|
2016 |
Gulshan et al. [3]
|
DR, DME |
CNN (InceptionV3) |
EyePACS (4997) / Messidor-2 (874) |
DR: Referable, non referable |
0.991/ 0.990 |
0.903/ 0.870 |
0.981/ 0.985 |
|
|
|
|
|
|
DME: Referable, non referable |
0.974 |
0.907 |
0.938 |
|
2012 |
Zheng et al. [44]
|
AMD |
Hierarchical trees + SVM |
ARIA (161) / STARE (97) |
AMD |
|
0.994 |
1,000 |
|
2011 |
Agurto et al. [8]
|
AMD, DR (3 FOV fundus) |
Feature extraction + Partial Least Squares |
RIST (378) / UTHSCSA (444) |
DR: Normal, sight-threatening |
0.890/ 0.920 |
0.950 |
0.500 |
|
|
|
|
|
|
DR-related: Microaneurysms, hemorrhages, exudates, neovascularization, etc. |
0.770-0.980 |
0.830–1.00 |
0.500 |
|
|
|
|
|
|
AMD-related: Drusen, Pigment. abnorm., GA |
0.770-0.920 |
0.88–1.000 |
0.500 |
|